Cargando…

Molecular and Cellular Dynamics in the Skin, the Lymph Nodes, and the Blood of the Immune Response to Intradermal Injection of Modified Vaccinia Ankara Vaccine

New vaccine design approaches would be greatly facilitated by a better understanding of the early systemic changes, and those that occur at the site of injection, responsible for the installation of a durable and oriented protective response. We performed a detailed characterization of very early in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenbaum, Pierre, Tchitchek, Nicolas, Joly, Candie, Stimmer, Lev, Hocini, Hakim, Dereuddre-Bosquet, Nathalie, Beignon, Anne-Sophie, Chapon, Catherine, Levy, Yves, Le Grand, Roger, Martinon, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996922/ https://www.ncbi.nlm.nih.gov/pubmed/29922280 http://dx.doi.org/10.3389/fimmu.2018.00870

Ejemplares similares

Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
por: Rosenbaum, Pierre, et al.
Publicado: (2021)

The Route of Vaccine Administration Determines Whether Blood Neutrophils Undergo Long-Term Phenotypic Modifications
por: Feraoun, Yanis, et al.
Publicado: (2022)

Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
por: Palgen, Jean-Louis, et al.
Publicado: (2018)

Leukocytospermia induces intraepithelial recruitment of dendritic cells and increases SIV replication in colorectal tissue explants
por: Cavarelli, Mariangela, et al.
Publicado: (2021)

Modulation of Cell Surface Receptor Expression by Modified Vaccinia Virus Ankara in Leukocytes of Healthy and HIV-Infected Individuals
por: Leite Pereira, Adrien, et al.
Publicado: (2020)

Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations
por: Palgen, Jean-Louis, et al.
Publicado: (2020)

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
por: Frey, Sharon E., et al.
Publicado: (2015)

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
por: Palgen, Jean-Louis, et al.
Publicado: (2021)

OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques
por: Dereuddre-Bosquet, N, et al.
Publicado: (2009)

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
por: Fovet, Claire-Maëlle, et al.
Publicado: (2019)

Mapping of SIVmac T-cell epitopes in cynomolgus macaques immunized with auxo-GTU-MultiSIV DNA by the intradermal route followed by electroporation
por: Corneau, A, et al.
Publicado: (2012)

Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques
por: Bollimpelli, Venkata S., et al.
Publicado: (2023)

Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae
por: Marlin, Romain, et al.
Publicado: (2019)

DNA methylation changes in metabolic and immune-regulatory pathways in blood and lymph node CD4 + T cells in response to SIV infections
por: Jochems, Simon P., et al.
Publicado: (2020)

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage
por: Lehmann, Michael H, et al.
Publicado: (2015)

Purification of modified vaccinia virus Ankara from suspension cell culture
por: Jordan, Ingo, et al.
Publicado: (2015)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
por: Jordan, Ingo, et al.
Publicado: (2013)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
por: Orlova, Olga Vladimirovna, et al.
Publicado: (2022)

Modified vaccinia Ankara–Bavarian Nordic vaccine against mpox in children
por: Turtle, Lance, et al.
Publicado: (2023)

LYMPH NODES AS A SOURCE OF NEUTRALIZING PRINCIPLE FOR VACCINIA
por: McMaster, Philip D., et al.
Publicado: (1937)

Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
por: Préville, Xavier, et al.
Publicado: (2015)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
por: Okeke, Malachy I., et al.
Publicado: (2017)

A vital gene for modified vaccinia virus Ankara replication in human cells
por: Sutter, Gerd
Publicado: (2020)

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
por: Czub, Markus, et al.
Publicado: (2005)

Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara
por: Jordan, Ingo, et al.
Publicado: (2009)

Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques
por: Todorova, Biliana, et al.
Publicado: (2017)

Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice
por: Lauterbach, Henning, et al.
Publicado: (2010)

Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice
por: Bohnen, C, et al.
Publicado: (2013)

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
por: Lülf, Anna-Theresa, et al.
Publicado: (2016)

Modified vaccinia virus Ankara as a vaccine against feline coronavirus: immunogenicity and efficacy
por: Hebben, Matthias, et al.
Publicado: (2004)

Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies
por: Garber, David A., et al.
Publicado: (2009)

Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model
por: Nörder, Miriam, et al.
Publicado: (2010)

Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections
por: Langenmayer, Martin C., et al.
Publicado: (2018)

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
por: Capone, Stefania, et al.
Publicado: (2020)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
por: López-Camacho, César, et al.
Publicado: (2019)

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development
por: Volz, A., et al.
Publicado: (2017)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
por: García-Arriaza, Juan, et al.
Publicado: (2021)

Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates
por: Flamar, A, et al.
Publicado: (2012)

SPADEVizR: an R package for visualization, analysis and integration of SPADE results
por: Gautreau, Guillaume, et al.
Publicado: (2017)

Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo
por: Flamar, Anne-Laure, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m5mh2cdfg3psmupknn6rejsp1n